AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $67.00M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| LM8 | Test June 19 2026 | 19/06/26 | 0 | 1 | |||
|
|||||||
| LM8 | TEST - Third Supplementary Target's Statement | 27/05/26 | 0 | 1 | |||
|
|||||||
See All Discussions
flyingace